Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism

D Armanini, M Boscaro, L Bordin… - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is a heterogeneous and extremely common disease with
symptoms that vary with the age of the patient, typically characterized by hyperandrogenism …

Obesity and dyslipidemia: a review of current evidence

J Vekic, A Stefanovic, A Zeljkovic - Current Obesity Reports, 2023 - Springer
Abstract Purpose of Review Obesity is accompanied by atherogenic dyslipidemia, a specific
lipid disorder characterized by both quantitative and qualitative changes of plasma …

Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)—searching for epigenetic factors

D Szukiewicz, S Trojanowski, A Kociszewska… - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of
reproductive age. Despite its incidence, the syndrome is poorly understood and remains …

Endocrine disrupting chemicals in polycystic ovary syndrome: the relevant role of the theca and granulosa cells in the pathogenesis of the ovarian dysfunction

M Jozkowiak, H Piotrowska-Kempisty, D Kobylarek… - Cells, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder
among women of reproductive age. The pathogenesis of PCOS remains elusive; however …

Probiotics and polycystic ovary syndrome: a perspective for management in adolescents with obesity

V Calcaterra, V Rossi, G Massini, F Casini, G Zuccotti… - Nutrients, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) affects a considerable percentage of females of
reproductive age. PCOS is an obesity-related condition and its effects are greatly amplified …

Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis

F Chiaffarino, S Cipriani, M Dalmartello, E Ricci… - European Journal of …, 2022 - Elsevier
We conducted a systematic review and meta-analyses of the prevalence of Polycystic Ovary
Syndrome (PCOS) and the frequency of its phenotypes in Europe and the USA, also …

PCOS in Adolescents—Ongoing riddles in diagnosis and treatment

B Meczekalski, O Niwczyk, A Kostrzak… - Journal of Clinical …, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in
women of reproductive age. A diagnosis of PCOS is established when a patient exhibits two …

[HTML][HTML] Polycystic ovarian syndrome: prevalence, predisposing factors, and awareness among adolescent and young girls of South India

A Jabeen, V Yamini, AR Amberina, MD Eshwar… - Cureus, 2022 - ncbi.nlm.nih.gov
Methods This was a prospective study that included 250 adolescent and young girls aged
between 13 and 25 years. Demographic details including age, educational status, and …

Positive effects of α-lactalbumin in the management of symptoms of polycystic ovary syndrome

V Cardinale, E Lepore, S Basciani, S Artale, M Nordio… - Nutrients, 2022 - mdpi.com
To date, the involvement of α-Lactalbumin (α-LA) in the management of polycystic ovary
syndrome (PCOS) refers to its ability to improve intestinal absorption of natural molecules …

Polycystic Ovary Syndrome: pathophysiology and controversies in diagnosis

D Fahs, D Salloum, M Nasrallah, G Ghazeeri - Diagnostics, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly
affects women in the reproductive age group. The disorder has features that propose a …